about
Neuroprotection as a Therapeutic Target for Diabetic RetinopathyRetinal Cell Degeneration in Animal ModelsInhibition of N-Methyl-D-aspartate-induced Retinal Neuronal Death by Polyarginine Peptides Is Linked to the Attenuation of Stress-induced Hyperpolarization of the Inner Mitochondrial Membrane PotentialMolecular Implications of the PPARs in the Diabetic Eye.Current knowledge on diabetic retinopathy from human donor tissues.In Vivo Evaluation of White Matter Integrity and Anterograde Transport in Visual System After Excitotoxic Retinal Injury With Multimodal MRI and OCT.Subconjunctivally Implanted Hydrogels for Sustained Insulin Release to Reduce Retinal Cell Apoptosis in Diabetic RatsCTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner.Effects of phlorizin on diabetic retinopathy according to isobaric tags for relative and absolute quantification-based proteomics in db/db mice.Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection.Neuropeptides and diabetic retinopathy.Biomarkers in diabetic retinopathy and the therapeutic implications.Abnormalities in glutamate metabolism and excitotoxicity in the retinal diseases.Neurovascular cross talk in diabetic retinopathy: Pathophysiological roles and therapeutic implications.Neuroprotective effects of citicoline in in vitro models of retinal neurodegeneration.Angiogenic Factors and Cytokines in Diabetic Retinopathy.NMDA receptor subunits have different roles in NMDA-induced neurotoxicity in the retina.Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients With Diabetic Retinopathy.Serine racemase deletion attenuates neurodegeneration and microvascular damage in diabetic retinopathy.Regression of retinal capillaries following N-methyl-D-aspartate-induced neurotoxicity in the neonatal rat retina.Protective effects of PF-4708671 against N-methyl-d-aspartic acid-induced retinal damage in rats.Rapamycin prevents N-methyl-D-aspartate-induced retinal damage through an ERK-dependent mechanism in rats.
P2860
Q26749178-245A5797-0D80-478C-A69E-3F4CAE496C3AQ26771160-09E2A2FE-D51C-47F4-8ECD-65D9A80289FBQ28388814-E092C861-223C-45D4-8EF4-D67146738698Q34594935-7CC2929B-2D5B-42B5-9204-57759789DA83Q35179240-F9149996-5C5D-481B-869B-C5FDA1BCF5E4Q35745174-2DBD42D5-C65F-4407-855C-371040CE9FD1Q36380233-F57E89A7-2A1D-46B8-864F-B7DD1E98E239Q36410404-523C83C0-1C8A-42A6-8022-F97C73C1B7E9Q36765788-27CBCC00-F800-4286-9789-1E7081D68F93Q37667292-BD16A169-6EB7-4D85-A1EB-2020A6721578Q38050159-DBF44C77-E503-490F-AFBD-2A364EBAE41BQ38169142-C0864A0E-919D-438E-9BEE-93834C309341Q38175406-014A7EA2-92B8-4D18-8FEF-1025FA80FC70Q38913007-F35ABEC5-DCF2-49D3-A082-484E9C5004F0Q39357651-3D68A0E8-FC2D-42B1-9B1F-C187F6A6602BQ41883466-CCB705D6-861F-43A1-8A50-551541D877FEQ42032233-881E67FC-1C60-4A69-8A69-B939745EE1BCQ43244563-E19E8FCD-6510-497A-8827-FCB2B8058451Q48303123-808882DA-EEB2-4AE3-AC7A-6F9790C2BDADQ50630590-F7114AA4-9B14-42D7-BEB4-2D069EF3E62AQ51668005-BEEF6F12-4F8E-43BA-8BB1-F0578FA3F7EBQ54378572-ACE9610F-88D4-4566-A35D-9B859A71C3B4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neuroprotection in diabetic retinopathy.
@en
type
label
Neuroprotection in diabetic retinopathy.
@en
prefLabel
Neuroprotection in diabetic retinopathy.
@en
P2860
P1476
Neuroprotection in diabetic retinopathy.
@en
P2093
Cristina Hernández
Rafael Simó
P2860
P2888
P304
P356
10.1007/S11892-012-0284-5
P577
2012-08-01T00:00:00Z
P6179
1035101016